CD44 and cancer: Interestingly, SNAI1-KO cells presented higher stem cell frequency and underwent a switch in the expression of cancer stemness signaling genes, with significant upregulation of epithelial KIT, ALDH1A1 and SOX2, and analogous downregulation of mesenchymal CD44 and SOX9 (Fig. 5C–H).